Patent Court gives decision in favor of Layla generics, nullifying its composition patent

Published: 2018-08-23 16:27:00
Updated: 2018-08-23 17:17:51

The composition patent of ‘Layla(PMG Pharm),’ a natural drug for osteoarthritis making approximately KRW 20 billion sales, received a decision of nullification at the Patent Court.

Mother’s Pharm led the nullification of its composition patent only in a half year at the Patent Court after the In...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.